One Health approach in human brucellosis: a comprehensive review of epidemiology, transmission, diagnosis, management, and control strategies
DOI:
https://doi.org/10.66585/ohmi.2026.2.0013Keywords:
Antimicrobial therapy, Brucellosis, Epidemiology, One Health, Zoonoses, SurveillanceAbstract
Brucellosis exemplifies the inseparable interconnection between animal health, human health, and environmental factors, making it an ideal candidate for application of the One Health framework. This comprehensive review examines the epidemiology, pathogenesis, transmission dynamics, clinical manifestations, diagnostic methodologies, treatment strategies, and prevention and control measures of human brucellosis through the lens of the One Health approach. The One Health concept recognizes that human health is inextricably linked to animal health and the health of the ecosystems in which they coexist. Brucellosis primarily affects livestock species, including cattle (Brucella abortus), sheep and goats (Brucella melitensis), swine (Brucella suis), and dogs (Brucella canis), with Brucella melitensis and Brucella abortus accounting for the majority of human infections worldwide. Transmission to humans occurs through direct contact with infected animals or their products, consumption of unpasteurized dairy products, and occupational exposure, making it a particular hazard for farmers, veterinarians, laboratory workers, and abattoir personnel. Effective control of human brucellosis requires coordinated veterinary, medical, and public health interventions. Vaccination of reservoir hosts, improved animal husbandry practices, pasteurization of dairy products, occupational safety measures, and robust surveillance systems form the pillars of a One Health-based control strategy. The review highlights significant gaps in integrated surveillance, transdisciplinary collaboration, and resource allocation in low- and middle-income endemic countries. Emerging challenges, including antimicrobial resistance, wildlife reservoirs, and climate-driven expansion of endemic zones, necessitate a holistic, ecosystem-based approach. Adopting the One Health paradigm in national and international brucellosis control programs offers the most promising pathway toward achieving sustained reduction in disease burden across species and ecosystems.
References
1. Bruce D. Note on the discovery of a micro-organism in Malta fever. Practitioner. 1887;39:161–170.
2. Franc KA, Krecek RC, Häsler BN, Arenas-Gamboa AM. Brucellosis remains a neglected disease in the developing world: A call for interdisciplinary action. BMC Public Health. 2018;18(1):125. https://doi.org/10.1186/s12889-017-5016-y
3. Laine CG, Johnson VE, Scott H, Arenas-Gamboa AM. Global estimate of human brucellosis incidence. Emerg Infect Dis. 2023;29(9):1789–1797. https://doi.org/10.3201/eid2909.230052
4. Roth F, Zinsstag J, Orkhon D, Chimed-Ochir G, Hutton G, Cosivi O, et al. Human health benefits from livestock vaccination for brucellosis: Case study. Bull World Health Organ. 2003;81(12):867–876. https://pmc.ncbi.nlm.nih.gov/articles/PMC2572379/
5. Franco MP, Mulder M, Gilman RH, Smits HL. Human brucellosis. Lancet Infect Dis. 2007;7(12):775–786. https://doi.org/10.1016/S
1473-3099(07)70286-4
6. Corbel MJ. Brucellosis in humans and animals. Geneva. WHO. 2006.
7. Ducrotoy MJ, Muñoz PM, Conde-Álvarez R, Blasco JM, Moriyón I. A systematic review of current immunological tests for the diagnosis of cattle brucellosis. Prev Vet Med. 2018;151:57–72. https://doi.org/1
0.1016/j.prevetmed.2018.01.003
8. American Veterinary Medical Association. One Health: A new professional imperative. Schaumburg (IL). American Veterinary Medical Association. 2008.
9. Zinsstag J, Schelling E, Waltner-Toews D, Tanner M. From ‘One Medicine’ to ‘One Health’ and systemic approaches to health and well-being. Prev Vet Med. 2011;101(3–4):148–156. https://doi.org
/10.1016/j.prevetmed.2010.07.003
10. Bidaisee S, Macpherson CNL. Zoonoses and One Health: A review of the literature. J Parasitol Res. 2014;2014:874345. https://doi.org/1
0.1155/2014/874345
11. FAO, OIE, WHO, UNEP. One Health Joint Plan of Action (2022–2026): Working together for the health of humans, animals, plants and the environment. Rome. Food and Agriculture Organization of the United Nations. 2022.
12. Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, et al. Global trends in emerging infectious diseases. Nature. 2008;451(7181):990–993. https://doi.org/10.1038/nature06536
13. Morens DM, Fauci AS. Emerging pandemic diseases: How we got to COVID-19. Cell. 2020;182(5):1077–1092. https://doi.org/10.1016
/j.cell.2020.08.021
14. FAO, OIE, WHO. The FAO-OIE-WHO collaboration: Sharing responsibilities and coordinating global activities to address health risks at the animal-human-ecosystems interfaces. A Tripartite Concept Note. Rome. FAO. 2010.
15. Gibbs EPJ. The evolution of One Health: A decade of progress and challenges for the future. Vet Rec. 2014;174(4):85–91. https://doi.org/10.1136/vr.g543
16. Garin-Bastuji B, Blasco JM. Brucella. In: Gillespie SH, Hawkey PM, editors. Principles and practice of clinical bacteriology. 2nd ed. Hoboken (NJ). Wiley. 2006. p. 289–310.
17. Grace D, Fetsch A, editors. Foodborne zoonotic diseases: An integrated One Health approach. Oxfordshire. CABI. 2018.
18. Gwida M, Al-Dahouk S, Melzer F, Rösler U, Neubauer H, Tomaso H. Brucellosis: Regionally emerging zoonotic disease? Croat Med J. 2010;51(4):289–295. https://doi.org/10.3325/cmj.2010.51.289
19. Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med. 2005;352(22):2325–2336. https://doi.org/10.1056/NEJMr
a050570
20. Seleem MN, Boyle SM, Sriranganathan N. Brucellosis: A re-emerging zoonosis. Vet Microbiol. 2010;140(3–4):392–398. https://doi.org/1
0.1016/j.vetmic.2009.12.011
21. Benkirane A. Ovine and caprine brucellosis: World distribution and control/eradication strategies in West Asia/North Africa region. Small Rumin Res. 2006;62(1–2):19–25. https://doi.org/10.1016/j.
smallrumres.2005.07.029
22. Godfroid J, Cloeckaert A, Liautard JP, Kohler S, Fretin D, Walravens K, et al. From the discovery of the Malta fever’s agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet Res. 2005;36(3):313–326. https://doi.or
g/10.1051/vetres:2005003
23. McDermott J, Grace D, Zinsstag J. Economics of brucellosis impact and control in low-income countries. Rev Sci Tech. 2013;32(1):249–261. https://doi.org/10.20506/rst.32.1.2201
24. Dean AS, Crump L, Greter H, Hattendorf J, Schelling E, Zinsstag J. Clinical manifestations of human brucellosis: A systematic review and meta-analysis. PLoS Negl Trop Dis. 2012;6(12):e1929. https://doi.org/10.1371/journal.pntd.0001929
25. Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis. 2006;6(2):91–99. https://doi.org/10.1016/S1473-3099(06)70382-6
26. Sofian M, Aghakhani A, Velayati AA, Banifazl M, Eslamifar A, Ramezani A. Risk factors for human brucellosis in Iran: A case-control study. Int J Infect Dis. 2008;12(2):157–161. https://doi.org/10.1016/j.ijid.2007.06.007
27. Benkirane A, Essamkaoui S, El Idrissi A, Lucchi N, Pfeiffer DU. A participatory assessment of animal disease priorities in Morocco. Prev Vet Med. 2007;79(1):1–10. https://doi.org/10.1016/j.prevetm
ed.2006.09.015
28. Mangen MJ, Otte J, Pfeiffer D, Chilonda P. Bovine brucellosis in sub-Saharan Africa: Estimation of sero-prevalence and impact on meat and milk offtake potential. Rome. FAO. 2002. (Livestock Policy Discussion Paper 8).
29. Singh BB, Dhand NK, Gill JP. Economic losses occurring due to brucellosis in Indian livestock populations. Prev Vet Med. 2015;119(3–4):211–215. https://doi.org/10.1016/j.prevetmed.20
15.03.013
30. Mantur BG, Amarnath SK, Shinde RS. Review of clinical and laboratory features of human brucellosis. Indian J Med Microbiol. 2007;25(3):188–202. https://doi.org/10.4103/0255-0857.34758
31. Lucero NE, Ayala SM, Escobar GI, Jacob NR. Brucella isolated in humans and animals in Latin America from 1968 to 2006. Epidemiol Infect. 2008;136(4):496–503. https://doi.org/10.1017/S09502688
07008795
32. World Organisation for Animal Health. Brucellosis: Infection with Brucella abortus, B. melitensis and B. suis. 2023. Available from: https://www.woah.org. Accessed 2025 May 20.
33. Steinberg BE, Maiorino CA. Brucellosis: Occupational risk and prevention. Occup Med (Lond). 2016;66(4):258–263. https://doi.or
g/10.1093/occmed/kqv183
34. Tuon FF, Gondolfo RB, Cerchiari N. Human-to-human transmission of Brucella: A systematic review. Trop Med Int Health. 2017;22(5):539–546. https://doi.org/10.1111/tmi.12861
35. Buzgan T, Karahocagil MK, Irmak H, Baran AI, Karsen H, Evirgen O, et al. Clinical manifestations and complications in 1028 cases of brucellosis: A retrospective evaluation and review of the literature. Int J Infect Dis. 2010;14(6):e469–e478. https://doi.org/10.1016/j.i
jid.2009.07.021
36. Traxler RM, Lehman MW, Bosserman EA, Guerra MA, Smith TL. A literature review of laboratory-acquired brucellosis. J Clin Microbiol. 2013;51(9):3055–3062. https://doi.org/10.1128/JCM.00765-13
37. Centers for Disease Control and Prevention. Bioterrorism agents/diseases. 2023. Available from: https://emergency.cdc.gov/bioterrorism/. Accessed 2025 May 20.
38. Moreno E, Moriyón I. Brucella melitensis: A nasty bug with hidden credentials for virulence. Proc Natl Acad Sci USA. 2002;99(1):1–3. https://doi.org/10.1073/pnas.022622699
39. Pizarro-Cerdá J, Moreno E, Sanguedolce V, Mège JL, Gorvel JP. Virulent Brucella abortus prevents lysosome fusion and is distributed within autophagosome-like compartments. Infect Immun. 1998;66(5):2387–2392. https://doi.org/10.1128/IAI.66.5.
2387-2392.1998
40. Comerci DJ, Martínez-Lorenzo MJ, Sieira R, Gorvel JP, Ugalde RA. Essential role of the VirB machinery in the maturation of the Brucella abortus-containing vacuole. Cell Microbiol. 2001;3(3):159–168. https://doi.org/10.1046/j.1462-5822.2001.00
102.x
41. Baldwin CL, Goenka R. Host immune responses to the intracellular bacteria Brucella: Does the bacteria instruct the host to facilitate chronic infection? Crit Rev Immunol. 2006;26(5):407–442. https://doi.org/10.1615/CritRevImmunol.v26.i5.20
42. Huang W, Garcia-Bocanegra I, Liu K, de Figueiredo P. The Brucella-containing vacuole: Navigating through the host cell. Front Cell Infect Microbiol. 2021;11:640172. https://doi.org/10.3389/fcimb.2
021.640172
43. Young EJ. Brucella species. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 7th ed. Philadelphia (PA). Churchill Livingstone. 2010. p. 2921–2925.
44. Skalsky K, Yahav D, Bishara J, Pitlik S, Leibovici L, Paul M. Treatment of human brucellosis: Systematic review and meta-analysis of randomised controlled trials. BMJ. 2008;336(7646):701–704. https://doi.org/10.1136/bmj.39497.50
0903.25
45. Huang H, Liu Q, Ma H, Tang D, Wang Z. The immunology of Brucella infection: Implications for diagnosis and vaccine design. Front Microbiol. 2022;13:988440. https://doi.org/10.3389/fmicb.2
022.988440
46. Corbel MJ. Brucellosis: Epidemiology and prevalence worldwide. In: Young EJ, Corbel MJ, editors. Brucellosis: Clinical and laboratory aspects. Boca Raton (FL). CRC Press. 1989. p. 25–40.
47. Ruben B, Band JD, Wong P, Colville J. Person-to-person transmission of Brucella melitensis. Lancet. 1991;337(8732):14–15. https://doi.org/10.1016/0140-6736(91)93327-M
48. Acha PN, Szyfres B. Zoonoses and communicable diseases common to man and animals. 3rd ed. Washington (DC). Pan American Health Organization. 2003.
49. Yagupsky P. Detection of Brucellae in blood cultures. J Clin Microbiol. 1999;37(11):3437–3442. https://doi.org/10.1128/JCM.
37.11.3437-3442.1999
50. Lyytikainen O, Ziese T, Schwartländer B, Matuszewska R, Mäkinen J, Pajunen E, et al. An outbreak of Brucella melitensis infections in a Finnish cheese factory. Scand J Infect Dis. 1997;29(5):497–502. https://doi.org/10.3109/00365549709011854
51. Nicoletti P. The epidemiology of bovine brucellosis. Adv Vet Sci Comp Med. 1980;24:69–98.
52. Haileselassie M, Taddele H, Adhana K, Kalayou S. Food safety knowledge and practices of abattoir and butchery shops and the risk for transmission of food-borne pathogens to consumers in Mekelle City, Ethiopia. Asian Pac J Trop Biomed. 2013;3(5):407–412. https://doi.org/10.1016/S2221-1691(13)60084-5
53. Olsen SC, Johnson R, Bengis R. Brucellosis in wildlife. Rev Sci Tech. 2012;31(3):939–952. https://doi.org/10.20506/rst.31.3.2153
54. Nayeri Fasaei B, Naserli S, Zahraei Salehi T, Saeedinia A, Behroozikhah A, Ashrafi Tamai I. New Brucella abortus S19 mutant to improve distinction between infected and vaccinated animals. Iran J Biotechnol. 2019;17(3):e2159. https://doi.org/10.29252/ijb.2159
55. Morgan ER, Wall R. Climate change and parasitic disease: Farmer adaptive capacity and mitigation opportunities. Trends Parasitol. 2009;25(2):83–90. https://doi.org/10.1016/j.pt.2008.11.004
56. Pappas G. The changing Brucella ecology: Novel reservoirs, new threats. Int J Antimicrob Agents. 2010;36 Suppl 1:S8–11. https://doi.org/10.1016/j.ijantimicag.2010.06.013
57. Ariza J, Bosilkovski M, Cascio A, Colmenero JD, Corbel MJ, Falagas ME, et al. Perspectives for the treatment of brucellosis in the 21st century: The Ioannina recommendations. PLoS Med. 2007;4(12):e317. https://doi.org/10.1371/journal.pmed.0040317
58. Colmenero JD, Reguera JM, Martos F, Sánchez-De-Mora D, Delgado M, Causse M, et al. Complications associated with Brucella melitensis infection: A study of 530 cases. Medicine (Baltimore). 1996;75(4):195–211. https://doi.org/10.1097/00005792-1996070
00-00003
59. Queipo-Ortuño MI, Colmenero JD, Reguera JM, García-Ordoñez MA, Pachón ME, Gonzalez M, et al. Rapid diagnosis of human brucellosis by SYBR Green I-based real-time PCR assay and melting curve analysis in serum samples. Clin Microbiol Infect. 2005;11(9):713–718. https://doi.org/10.1111/j.1469-0691.2005.0
1212.x
60. Ozturk R, Mert A, Kocak F, Ozaras R, Koksal F, Tabak F, et al. The diagnosis of brucellosis by use of BACTEC 9240 blood culture system. Diagn Microbiol Infect Dis. 2002;44(2):133–135. https://doi.org/10.1016/S0732-8893(02)00434-X
61. Bosilkovski M, Krteva L, Caparoska S, Dimzova M. Hip arthritis in brucellosis: A study of 33 cases in the Republic of Macedonia (FYROM). Int J Infect Dis. 2004;8(6):370–374. https://doi.org/10.
1016/j.ijid.2004.04.012
62. Erdem H, Elaldi N, Batirel A, Aliyu S, Balkan II, Surucuoglu S, et al. Comparison of six different treatment regimens in the treatment of spinal brucellosis. Infection. 2017;45(3):371–376. https://doi.org/
10.1007/s15010-017-0993-0
63. Roca B. Brucellosis. Rev Clin Esp. 2013;213(3):141–149. https://doi.org/10.1016/j.rce.2013.01.003
64. Al-Sous MW, Bohlega S, Al-Kawi MZ, Alwatban J, McLean DR. Neurobrucellosis: Clinical and neuroimaging correlation. AJNR Am J Neuroradiol. 2004;25(3):395–401.
65. Mailles A, Rautureau S, Le Horgne JM, Poignet-Leroux B, d’Arnoux C, Dennetière G, et al. Re-emergence of brucellosis in cattle in France and risk for human health. Euro Surveill. 2012;17(30):20227. https://doi.org/10.2807/ese.17.30.20227-en
66. Gul HC, Erdem H. Brucellosis (Brucella species). In: Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 8th ed. Philadelphia (PA). Elsevier. 2015. p. 2584–2589.
67. Araj GF. Update on laboratory diagnosis of human brucellosis. Int J Antimicrob Agents. 2010;36 Suppl 1:S12–17. https://doi.org/10.10
16/j.ijantimicag.2010.06.014
68. Araj GF, Kaufman L, Boustany S, Reiss E. Evaluation of the double diffusion tube agglutination test for detection of Brucella antibodies in humans. Eur J Clin Microbiol. 1986;5(2):186–188. https://doi.or
g/10.1007/BF02014921
69. Garin-Bastuji B, Marcos R, Ferreira-Jorge H, Blasco JM. Specificity of the Rose Bengal test in human brucellosis diagnosis in France. Eur J Clin Microbiol Infect Dis. 1998;17(2):98–103. https://doi.org/10.
1007/BF01683686
70. Altuglu I, Zeytinoglu A, Bilgic A, Altintoprak AE. Comparison of conventional tube agglutination test and ELISA in the diagnosis of brucellosis. New Microbiol. 2005;28(1):31–35.
71. Zerva L, Bourantas K, Mitka S, Kansouzidou A, Legakis NJ. Serum is the preferred clinical specimen for diagnosis of human brucellosis by PCR. J Clin Microbiol. 2001;39(4):1661–1664. https://doi.org/10.1
128/JCM.39.4.1661-1664.2001
72. Lucero NE, Escobar GI, Ayala SM, Jacob N. Diagnosis of human brucellosis caused by Brucella canis. J Med Microbiol. 2005;54(Pt 5):457–461. https://doi.org/10.1099/jmm.0.45927-0
73. Navarro E, Escribano J, Fernández JA, Solera J. Comparison of three different PCR methods for detection of Brucella spp. in human blood samples. FEMS Immunol Med Microbiol. 2002;34(2):147–151. https://doi.org/10.1111/j.1574-695X.2002.tb00617.x
74. Whatmore AM, Perrett LL, MacMillan AP. Characterisation of the genetic diversity of Brucella by multilocus sequencing. BMC Microbiol. 2007;7:34. https://doi.org/10.1186/1471-2180-7-34
75. Gwida M, Neubauer H, Ilhan Z, Schmoock G, Melzer F. Identification and molecular characterisation of Brucella species from livestock and humans in Africa with emphasis on the Middle East. Ann Agric Environ Med. 2012;19(1):5–10.
76. Poester FP, Nielsen K, Samartino LE, Yu WL. Diagnosis of brucellosis. Open Vet Sci J. 2010;4:46–60. https://doi.org/10.2174
/1874318801004010046
77. World Health Organization. WHO Model Formulary 2008: Brucellosis. Geneva. WHO Press. 2009.
78. Solís García del Pozo J, Solera J. Systematic review and meta-analysis of randomized clinical trials in the treatment of human brucellosis. PLoS One. 2012;7(2):e32090. https://doi.org/10.1371/
journal.pone.0032090
79. Doganay M, Aygen B. Human brucellosis: An overview. Int J Infect Dis. 2003;7(3):173–182. https://doi.org/10.1016/S1201-9712(03)
90046-5
80. Khuri-Bulos NA, Daoud AH, Azab SM. Treatment of childhood brucellosis: Results of a prospective trial on 113 children. Pediatr Infect Dis J. 1993;12(5):377–381. https://doi.org/10.1097/000064
54-199305000-00003
81. Blasco JM, Moriyón I. Brucella abortus strain 19 vaccine and Brucella melitensis Rev.1 vaccine: An update. In: López-Goñi I, O’Callaghan D, editors. Brucella: Molecular microbiology and genomics. Norfolk (UK). Caister Academic Press. 2012. p. 17–48.
82. Moriyón I, Grilló MJ, Monreal D, González D, Marín C, López-Goñi I, et al. Rough vaccines in animal brucellosis: Structural and genetic basis and present status. Vet Res. 2004;35(1):1–38. https://doi.org/10.1051/vetres:2003037
83. Perkins SD, Smither SJ, Atkins HS. Towards a Brucella vaccine for humans. FEMS Microbiol Rev. 2010;34(3):379–394. https://doi.or
g/10.1111/j.1574-6976.2009.00202.x
84. Crawford RP, Huber JD, Adams BS. Epidemiology and surveillance. In: Nielsen K, Duncan JR, editors. Animal brucellosis. Boca Raton (FL). CRC Press. 1990. p. 131–151.
85. Ducrotoy MJ, Bertu WJ, Matope G, Cadmus S, Conde-Álvarez R, Gusi AM, et al. Brucellosis in sub-Saharan Africa: Current challenges for management, diagnosis and control. Acta Trop. 2017;165:179–193. https://doi.org/10.1016/j.actatropica.2015.10.023
86. Mian LS, Maag H, Tacal JV. Isolation of Brucella from commercially produced chorizo. J Vet Diagn Invest. 1990;2(2):166–168. https://doi.org/10.1177/104063879000200218
87. World Health Organization. WHO laboratory biosafety manual. 4th ed. Geneva. World Health Organization. 2020.
88. Schelling E, Diguimbaye C, Daoud S, Nicolet J, Zinsstag J. Brucellosis and Q fever seroprevalences of nomadic pastoralists and their livestock in Chad. Prev Vet Med. 2003;61(4):279–293. https://doi.org/10.1016/j.prevetmed.2003.08.004
89. Zinsstag J, Schelling E, Roth F, Bonfoh B, de Savigny D, Tanner M. Human benefits of animal interventions for zoonosis control. Emerg Infect Dis. 2007;13(4):527–531. https://doi.org/10.3201/eid1304.
060827
90. Hay SI, George DB, Moyes CL, Brownstein JS. Big data opportunities for global infectious disease surveillance. PLoS Med. 2013;10(4):e1001413. https://doi.org/10.1371/journal.pmed.1001
413
91. World Health Organization. International Health Regulations (2005). 3rd ed. Geneva. World Health Organization. 2016. https://www.who.int/publications/i/item/9789241580496
92. Abela-Ridder B, Sikkema R, Hartskeerl RA. Estimating the burden of human leptospirosis. Int J Antimicrob Agents. 2010;36 Suppl 1:S5–7. https://doi.org/10.1016/j.ijantimicag.2010.06.012
93. Wong YP, Othman S, Lau YL, Radu S, Chee HY. Loop-mediated isothermal amplification (LAMP): a versatile technique for detection of micro-organisms. J Appl Microbiol. 2018;124(3):626-643. https://doi.org/10.1111/jam.13647
94. Mortensen JE, Moore DG, Clarridge JE, Young EJ. Antimicrobial susceptibility of clinical isolates of Brucella. Diagn Microbiol Infect Dis. 1986;5(2):163–169. https://doi.org/10.1016/0732-8893(86)9
0075-9
95. Roca I, Akova M, Baquero F, Carlet J, Cavaleri M, Coenen S, et al. The global threat of antimicrobial resistance: Science for intervention. New Microbes New Infect. 2015;6:22–29. https://doi.org/10.1016/j.nmni.2015.02.007
96. Corner LA. The role of wild animal populations in the epidemiology of tuberculosis in domestic animals: How to assess the risk. Vet Microbiol. 2006;112(2–4):303–312. https://doi.org/10.1016/j.vet
mic.2005.11.030
97. Huang H, Huang Y, Xia P, Liu Q, Ma H, Wang Z, et al. Vaccines against brucellosis: Moving forward to a potentially safe, protective, and cost-effective vaccine candidate. Front Immunol. 2023;14:1202809. https://doi.org/10.3389/fimmu.2023.1202809
98. Wareth G, Abdeen A, Ali H, Bardenstein S, Blasco J-M, Cardoso R., et al. Brucellosis in the Mediterranean countries: History, prevalence, distribution, current situation and attempts at surveillance and control. Paris. Office International des Epizooties. 2019. (OIE Technical Series; 12). Available from: https://agris.fao.org/search/en/providers/125096/records/67a0b54720478411b0263eeb
99. Schelling E, Bechir M, Ahmed MA, Wyss K, Randolph TF, Zinsstag J. Human and animal vaccination delivery to remote nomadic families, Chad. Emerg Infect Dis. 2007;13(3):373–379. https://doi.org/10.3201/eid1303.060391
100. Mableson HE, Okello A, Picozzi K, Welburn SC. Neglected zoonotic diseases—The long and winding road to advocacy. PLoS Negl Trop Dis. 2014;8(6):e2800. https://doi.org/10.1371/journal.pntd.00028
00
101. Crump JA, Murdoch DR, Baker MG. Aiming to reduce the global burden of typhoid fever and its complications: Setting targets and measuring progress. J Infect Dis. 2004;190 Suppl 1:S102–109. https://doi.org/10.1086/422347
102. Jamil T, Akar K, Erdenlig S, Murugaiyan J, Sandalakis V, Boukouvala E, et al. Spatio-temporal distribution of brucellosis in European terrestrial and marine wildlife species and its regional implications. Microorganisms. 2022;10(10):1970. https://doi.org/
10.3390/microorganisms10101970
Published
Versions
- 2026-05-12 (2)
- 2026-05-05 (1)
Issue
Section
License
Copyright (c) 2026 Jinal Patel (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
